These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia. Mantha S, Jacobs MI, Savage DG. J Clin Oncol; 2005 Aug 20; 23(24):5841-3. PubMed ID: 16110039 [No Abstract] [Full Text] [Related]
10. In defence of the use of modern chemotherapy regimens for the treatment of patients with chronic lymphocytic leukaemia. Tam CS. Intern Med J; 2009 Dec 20; 39(12):858-9. PubMed ID: 20233254 [No Abstract] [Full Text] [Related]
13. Low-dose thalidomide in combination with oral fludarabine and cyclophosphamide is ineffective in heavily pretreated patients with chronic lymphocytic leukemia. Giannopoulos K, Dmoszyńska A, Roliński J. Leuk Res; 2007 Mar 20; 31(3):411-2. PubMed ID: 16978694 [No Abstract] [Full Text] [Related]
14. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia]. Hanamura A, Hayakawa M, Naito K. Rinsho Ketsueki; 2005 Jan 20; 46(1):13-8. PubMed ID: 16708912 [Abstract] [Full Text] [Related]
15. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia. Haines I, Elliott P, Stanley R. Intern Med J; 2009 Apr 20; 39(4):269-71. PubMed ID: 19402870 [No Abstract] [Full Text] [Related]
16. Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma. McLaughlin P, Hagemeister FB, Rodriguez MA, Sarris AH, Pate O, Younes A, Lee MS, Dang NH, Romaguera JE, Preti AH, McAda N, Cabanillas F. Semin Oncol; 2000 Dec 20; 27(6 Suppl 12):37-41. PubMed ID: 11225999 [Abstract] [Full Text] [Related]